Nurix Therapeutics, INC. (NRIX) — SC 13G/A Filings
All SC 13G/A filings from Nurix Therapeutics, INC.. Browse 11 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (11)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 7, 2024
- SC 13G/A Filing — Jun 7, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
Wasatch Advisors Maintains 5.7% Stake in Nurix Therapeutics
— Feb 9, 2024 Risk: low
Wasatch Advisors LP, an investment adviser, filed an amended SC 13G/A on February 9, 2024, indicating a change in its ownership of Nurix Therapeutics, Inc. comm -
BlackRock Amends Nurix Therapeutics Stake as of Dec 31, 2023
— Jan 24, 2024
BlackRock Inc. filed an amended Schedule 13G/A on January 24, 2024, indicating a change in its ownership of Nurix Therapeutics, Inc. common stock as of December -
State Street Corp. Updates Passive Stake in Nurix Therapeutics
— Jan 23, 2024
State Street Corporation, a major financial institution, filed an amended Schedule 13G/A on January 23, 2024, indicating its ownership of Nurix Therapeutics, In
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX